Literature DB >> 11564977

Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension.

K B Atkins1, D Johns, S Watts, R Clinton Webb, F C Brosius.   

Abstract

OBJECTIVE: Because glucose uptake and metabolism can affect vascular smooth muscle cell function, we proposed that animals with hypertension might develop alterations in glucose transporter expression in vascular smooth muscle cells that were responsible for some of the vascular abnormalities characteristic of hypertension. DESIGN AND
METHOD: Male Sprague-Dawley rats (250-300 g) were left uni-nephrectomized and either implanted or not with deoxycorticosterone acetate (DOCA, 200 mg/kg) impregnated silastic. All animals were fed normal rat chow. The DOCA-implanted rats were given water supplemented to 1% NaCl and 0.2% KCl for 7, 14 or 28 days.
RESULTS: The insulin-response glucose transporter (GLUT4) polypeptide levels were depressed several-fold in aortae and carotid arteries from DOCA-salt hypertensive rats compared with sham rats. Uptake of the glucose analog, 2-deoxyglucose (2-DOG), was also reduced 53% in hypertensive compared with sham aortae. There were no changes in GLUT4 expression in other tissues in the DOCA-salt animals, nor were there significant changes in aortae from spontaneously hypertensive rat/stroke prone animals. As previously demonstrated, carotid arteries from DOCA-salt animals exhibited a significant increased contractile sensitivity to ergonovine. Inhibition of glucose metabolism with 2-DOG in sham arteries caused a marked enhancement of contractile responsiveness to ergonovine, whereas 2-DOG had no effect on the already enhanced contractility of DOCA-salt arteries, suggesting that reduction in glucose uptake and metabolism substantially increases the contractile response of DOCA-salt arteries.
CONCLUSIONS: Alterations in glucose uptake and metabolism in vascular smooth muscle cells may participate in the contractile abnormalities characteristic of certain forms of hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564977     DOI: 10.1097/00004872-200109000-00009

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression.

Authors:  Carolyn L Buller; Robert D Loberg; Ming-Hui Fan; Qihong Zhu; James L Park; Eileen Vesely; Ken Inoki; Kun-Liang Guan; Frank C Brosius
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-23       Impact factor: 4.249

2.  Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells.

Authors:  Rajkumar Pyla; Ninu Poulose; John Y Jun; Lakshman Segar
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-09       Impact factor: 4.249

3.  Maintenance of GLUT4 expression in smooth muscle prevents hypertension-induced changes in vascular reactivity.

Authors:  Kevin B Atkins; Yoshinori Seki; Jharna Saha; Felix Eichinger; Maureen J Charron; Frank C Brosius
Journal:  Physiol Rep       Date:  2015-02-12

4.  Role of GLUT4 on angiotensin 2-induced systemic and renal hemodynamics.

Authors:  Ighodaro Igbe; Eric Kelly Omogbai; Adebayo O Oyekan
Journal:  J Exp Pharmacol       Date:  2013-04-04

5.  Insulin-Independent and Dependent Glucose Transporters in Brain Mural Cells in CADASIL.

Authors:  Mahmod Panahi; Patricia Rodriguez Rodriguez; Seyed-Mohammad Fereshtehnejad; Donia Arafa; Nenad Bogdanovic; Bengt Winblad; Angel Cedazo-Minguez; Juha Rinne; Taher Darreh-Shori; Yoshiki Hase; Raj N Kalaria; Matti Viitanen; Homira Behbahani
Journal:  Front Genet       Date:  2020-09-15       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.